
Sign up to save your podcasts
Or
Cast:
Joel Topf
Jennie Lin
Swapnil Hiremath
Matt Sparks
Show Notes:
NephJC Coverage of MENTOR: http://www.nephjc.com/news/mentor
MENTOR: https://www.nejm.org/doi/full/10.1056/NEJMoa1814427
KDIGO Membranous recommendations: https://kdigo.org/wp-content/uploads/2017/02/KDIGO-2012-GN-Guideline-English.pdf
2017 Kidney Week Abstract: https://www.asn-online.org/education/kidneyweek/2017/program-abstract.aspx?controlId=2831149
PEXIVAS: http://www.nephjc.com/news/pexivasearly
Heymann Nephritis: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042693/
Susan Quaggin: https://www.feinberg.northwestern.edu/faculty-profiles/az/profile.html?xid=26269
Manasi Bapat on non-inferiority trials: http://www.nephjc.com/news/2019/7/8/understanding-the-vortex-of-non-inferiority-trials
Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan: https://www.sciencedirect.com/science/article/pii/S0085253815498503
Nice review of Membranous by Alfaadhel and Cattrran that purports to say than CNI are the standard therapy for idiopathic membranous. (It doesn’t) https://www.ncbi.nlm.nih.gov/pubmed/27536673?dopt=Abstract
Pablo Garcia saves the day: https://twitter.com/PabloGarciaMD/status/1148767319323099136?s=20
Larry beck’s land mark study demonstrating antiPLA2r as the antigen in idiopathic membranous. https://www.nejm.org/doi/full/10.1056/NEJMoa0810457
GEMRITUX Study: https://www.ncbi.nlm.nih.gov/pubmed/27352623
Jennie Lin’s How to Be a Nephrology Fellow, Choose Your Own Adventure: https://twitter.com/jenniejlin/status/1156329711057981442?s=20
CJASN How to Review a Paper Podcast: https://www.asn-online.org/media/podcast/CJASN/2019_07_23_How_to_Write_a_Cons.mp3
4.9
166166 ratings
Cast:
Joel Topf
Jennie Lin
Swapnil Hiremath
Matt Sparks
Show Notes:
NephJC Coverage of MENTOR: http://www.nephjc.com/news/mentor
MENTOR: https://www.nejm.org/doi/full/10.1056/NEJMoa1814427
KDIGO Membranous recommendations: https://kdigo.org/wp-content/uploads/2017/02/KDIGO-2012-GN-Guideline-English.pdf
2017 Kidney Week Abstract: https://www.asn-online.org/education/kidneyweek/2017/program-abstract.aspx?controlId=2831149
PEXIVAS: http://www.nephjc.com/news/pexivasearly
Heymann Nephritis: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042693/
Susan Quaggin: https://www.feinberg.northwestern.edu/faculty-profiles/az/profile.html?xid=26269
Manasi Bapat on non-inferiority trials: http://www.nephjc.com/news/2019/7/8/understanding-the-vortex-of-non-inferiority-trials
Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan: https://www.sciencedirect.com/science/article/pii/S0085253815498503
Nice review of Membranous by Alfaadhel and Cattrran that purports to say than CNI are the standard therapy for idiopathic membranous. (It doesn’t) https://www.ncbi.nlm.nih.gov/pubmed/27536673?dopt=Abstract
Pablo Garcia saves the day: https://twitter.com/PabloGarciaMD/status/1148767319323099136?s=20
Larry beck’s land mark study demonstrating antiPLA2r as the antigen in idiopathic membranous. https://www.nejm.org/doi/full/10.1056/NEJMoa0810457
GEMRITUX Study: https://www.ncbi.nlm.nih.gov/pubmed/27352623
Jennie Lin’s How to Be a Nephrology Fellow, Choose Your Own Adventure: https://twitter.com/jenniejlin/status/1156329711057981442?s=20
CJASN How to Review a Paper Podcast: https://www.asn-online.org/media/podcast/CJASN/2019_07_23_How_to_Write_a_Cons.mp3
134 Listeners
313 Listeners
494 Listeners
278 Listeners
3,324 Listeners
1,113 Listeners
193 Listeners
717 Listeners
514 Listeners
349 Listeners
249 Listeners
426 Listeners
251 Listeners
364 Listeners
136 Listeners